Samyang Biopharm USA Revenue

Biotechnology Research • Cambridge, Massachusetts, United States • 1-10 Employees

Samyang Biopharm USA revenue & valuation

Annual revenue	$342,220
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,100,000
Total funding	No funding

Key Contact at Samyang Biopharm USA

Helen Cho

President

Company overview

Headquarters	600 One Kendall Square, Suite 202, Cambridge, MA 02139, US
Phone number	+16178126960
Websites	samyangbiopharm.com samyang.com
NAICS	541714
Founded	2018
Employees	1-10
Socials

Samyang Biopharm USA Email Formats

Samyang Biopharm USA uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@samyang.com), used 100% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@samyang.com	100%

About Samyang Biopharm USA

Samyang Biopharm USA, Inc. (“SYBUSA”) was founded in 2018 with the headquarters in One Kendall Square, Cambridge, MA. Playing a vital role as a business hub in the United States, SYBUSA focuses on out-licensing its nucleic acid drug delivery system developed in Samyang Biopharm, a biopharmaceutical business unit in Korea. Over the next few years, SYBUSA will also focus on building partnerships with pharmaceutical companies and co-development joint ventures in the United States.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Vice President

Funding Data

Samyang Biopharm USA has never raised funding before.

Frequently asked questions

Samyang Biopharm USA is located in Cambridge, Massachusetts, US.

You can reach Samyang Biopharm USA at +16178126960.

Samyang Biopharm USA generates an estimated annual revenue of $342,220. This revenue figure reflects the company's market position and business performance in its industry.

Samyang Biopharm USA has an estimated valuation of $1,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Samyang Biopharm USA was founded in 2018, making it 8 years old. The company has established itself as a significant player in its industry over this time.

Samyang Biopharm USA has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Samyang Biopharm USA

Helen Cho

President

4.8

40,000 users